Clinical Trials

Open Clinical Trials

Department

Disease

Investigator

Study Sponsor

Title (click for details)

CRITIAL CARE/ PHYSCIAL THERAPY

PHYSICAL THERAPY IN ICU

Timothy Evans MD

None

EXERCISE STUDY

EMERGENCY DEPARTMENT

ABSCESSES

Michael Darracq MD

Emergency Medicine

ABSCESS

EMERGENCY DEPARTMENT

DENTAL PAIN

Brain Chinnock MD

Emergency Medicine

DENTAL BLOCK

EMERGENCY DEPARTMENT

HEMMORHAGE

Danielle Campagne MD

Emergency Medicine

COMBAT GAUZE

EMERGENCY DEPARTMENT

LACERATIONS

Brian Chinnock MD

Emergency Medicine

VICRYL RAPIDE

EMERGENCY DEPARTMENT

URETHRITIS

Brian Chinnock MD

Emergency Medicine

URETHRITIS

EMERGENCY DEPARTMENT

URINARY TRACT INFECTION

Brian Chinnock MD

Emergency Medicine

URINALYSIS

HEM/ONC

ALL CANCER

Haifaa Abdulhaq MD

ECOG (NCI)

EA9181

HEM/ONC

BREAST CANCER

Constance Stoehr MD

Alliance (NCI)

A011801

HEM/ONC

COLORECTAL CANCER

Uzair Chaudhary MD

Mirati Therapeutics Inc.

849-010

HEM/ONC

FOLLICULAR LYMPHOMA

Haifaa Abdulhaq MD

Epizyme Inc.

EZH-302

HEM/ONC

FOLLICULAR LYMPHOMA

Haifaa Abdulhaq MD

UCHMC

UCHMC1916

HEM/ONC

GENITOURINARY CANCER

Uzair Chaudhary MD

Alliance (NCI)

A031702

HEM/ONC

HEMATOLOGY CANCERS

Mohammed Bukari MD

CCFMG

MONTELUKAST

HEM/ONC

MULTIPLE MYELOMA

Haifaa Abdulhaq MD

Pfizer Inc.

C1071005

HEM/ONC

MULTIPLE TYPES OF CANCER

Uzair Chaudhary MD

Bristol Myers Squibb

CA052-002

HEM/ONC

MULTIPLE TYPES OF CANCER

Haifaa Abdulhaq MD

Investigator

SURVIVORSHIP

HEM/ONC

NON-SMALL CELL LUNG CANCER

Uzair Chaudhary MD

Alliance (NCI)

A151216

HEM/ONC

NON-SMALL CELL LUNG CANCER

Uzair Chaudhary MD

ECOG (NCI)

E4512

HEM/ONC

OVARIAN OR PERITONEAL CANCER

Trung “Tim” Nguyen DO MBA

NRG

NRG-GY019

HEM/ONC

PROSTATE CANCER

Uzair Chaudhary MD

AstraZeneca

D361EC00001

HEM/ONC

PROSTATE CANCER

Uzair Chaudhary MD

SWOG (NCI)

S1802

HEM/ONC

RENAL CANCER

Uzair Chaudhary MD

Alliance (NCI)

A031704

HEPATOLOGY

CHILDHOOD NASH

Marina Roytman MD

CCFMG

CHILD NASH

HEPATOLOGY

END STAGE LIVER DISEASE

Marina Roytman MD

PCORI/Albert Einstein Healthcare Network

PAL LIVER

HEPATOLOGY

LIVER CIRRHOSIS

Marina Roytman MD

Madrigal Pharmaceuticals

MEASTRO-NASH

HEPATOLOGY

LIVER CIRRHOSIS

Marina Roytman MD

Salix Pharmaceuticals, INC.

RED-C

INFECTIOUS DISEASE

MONKEY POX

Geetha Sivasubramanian MD

CDC

STOMP

INFECTIOUS DISEASE

VALLEY FEVER

Robert Libke MD

Geetha Sivasubramanian MD

Mohamed Fayed MD

None

COCCI REGISTRY

INFECTIOUS DISEASE

VALLEY FEVER

Geetha Sivasubramanian MD

MiraVista Diagnostics

COCCI

INFECTIOUS DISEASE

VALLEY FEVER

Mohamed Fayed MD

UC Merced

Reg T-Cell

INFECTIOUS DISEASE

VALLEY FEVER

Mohamed Fayed MD

NIH

SANDS

OB/GYN

CANCER RISK

Amy Autry MD

UCSF

DREAM

PULMONARY

ASTHMA

Jose Joseph-Vempilly MD

BRITZ Award

REVOREA

PULMONARY

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Vipal Jain MD

Sanofi

AERIFY

PULMONARY

EXTRACORPOREAL MEMBRANE OXYGENATION

Mohamed Fayed MD

NONE

ECMO Registry

PULMONARY

IDIOPATHIC PULMOARY FIBROSIS

Mohamed Fayed MD

Genentech, INC.

MOONSCAPE

PULMONARY

LUNG NODULE REGISTRY

Michael Peterson MD

Mohamed Fayed MD

None

LNC

PULMONARY

MYCOBACTERIUM AVIUM COMPLEX

Mohamed Fayed MD

SPERO Therapeutics

SPERO

PULMONARY

MYCOBACTERIUM AVIUM COMPLEX

Mohamed Fayed MD

Insmed Incorporated

ENCORE

PULMONARY

PULMOARY ARTERIAL HYPERTENSION

Eyad Almasri MD

Lung Bio Tech

ARTISAN

PULMONARY

PULMOARY ARTERIAL HYPERTENSION

Eyad Almasri MD

Trio Health Analytics

ANNEX 1

SURGERY

ABDOMINAL AORTIC AND AORTO-ILIAC ANEURYSMS

Sammy Siada DO

Terumo Aortic

IP-0021-20

SURGERY

PERIPHERAL ARTERIAL DISEASE

Leigh Ann O’ Banion

Shockwave Medical Inc.

SHOCKWAVE

 


 

Enrolling Clinical Trials

Early rehabilitation in critically ill patients in the intensive care unit

Early rehabilitation using functional electrical stimulation assisted supine cycling effect on muscle mass, strength, biomarkers, and functional outcomes as compared with conventional exercise and early mobilization alone in critically ill patients in the intensive care unit

For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].

Dr. Timothy Evans                                       Harsha Deoghare, DPT                  Paul Smith, DPT
Division of Pulmonary and                         Associate Dean of Research         Acute Care Rehab Services

Critical Care Medicine                                Western University                          Community Health System
UCSF Fresno  


Is Routine Packing of Cutaneous Abscesses Necessary?

Examine patients undergoing incision and drainage of cutaneous abscesses to determine if routine packing of the abscess cavity affects the need for further inte Examine patients undergoing incision and drainage of cutaneous abscesses to determine if routine packing of the abscess cavity affects the need for further interventions

For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at jannet [email protected].

Dr. Michael Darracq
Emergency Medicine
UCSF Fresno 


Efficacy of ED Provider-Performed Dental Block for Pain Relief in ED Patients Presenting with Dental Pain

For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at jannet [email protected].

Dr. Brian Chinnock
Emergency Medicine
UCSF Fresno  


Combat Gauze© in Trauma Patients: An observational study of a hemostatic agent versus plain gauze in the ER setting

For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at jannet [email protected].

Dr. Danielle Campagne
Emergency Medicine
UCSF Fresno


Vicryl Rapide versus Nonabsorbable Suture in Repair of Simple Traumatic Extremity and Trunk Lacerations in Adult Patients

For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at jannet [email protected].

Dr. Brian Chinnock
Emergency Medicine
UCSF Fresno  

 


History, Symptomatology, and Physical Exam Features and Under-and Overtreatment of GC and UTI in Male Urethritis Patient in the ED

For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at [email protected].

Dr. Brian Chinnock
Emergency Medicine
UCSF Fresno   


Concordance of Patients UTI Symptoms with Practitioner Perception of UTI Symptoms

For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at [email protected].

Dr. Brian Chinnock
Emergency Medicine
UCSF Fresno   


A Phase III Randomized Trial of Steroids + TKI Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-positive ALL in Adults

For more information about this trial, please contact Kelly Meehan at [email protected]

Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno  


The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib

For more information about this trial, please contact Kelly Meehan at [email protected]

Dr. Constance Stoehr
Division of Hematology/Oncology
UCSF Fresno  


A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced  Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy

For more information about this trial, please contact Alejandra Valencia at [email protected]

Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno


A Phase 1B/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study of Tazemetostat or Placebo in Combination with Lenalidomide Plus Rituximab in Subjects with Relapsed/Refractory Follicular Lymphoma

For more information about this trial, please contact Alejandra Valencia at [email protected]

Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno   


Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma

For more information about this trial, please contact Lizbeth Gasga at [email protected]

Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno   


A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)

For more information about this trial, please contact Kelly Meehan at [email protected]

Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno


A Phase II Study, Evaluating the Efficacy of Montelukast (Singulair) in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions

For more information about this trial, please contact Kelly Meehan at [email protected]

Dr. Mohameed Bukari
Division of Hematology/Oncology
UCSF Fresno 


(MAGNETISMM-5) An Open-Label, 3-Arm, Multicenter, Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants with Relapsed/Refractory Multiple Myeloma Who Have Received at Least 1 Prior Line of Therapy Including Lenalidomide and A Proteasome Inhibitor 

For more information about this trial, please contact Lizbeth Gasga at [email protected]

Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno   


A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination with Nivolumab or Docetaxel in Participants with Advanced Solid Tumors

For more information about this trial, please contact Alejandra Valencia at [email protected]

Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno


Improving Survivorship Care for Older Adults after Chemotherapy

For more information about this trial, please contact Kelly Meehan at [email protected]

Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno    


Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

For more information about this trial, please contact Kelly Meehan at [email protected]

Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno


A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

For more information about this trial, please contact Kelly Meehan at [email protected]

Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno


A Randomized Phase III, Two-Arm Trial of Paclitaxel/ Carboplatin/ Maintenance Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum

For more information about this trial, please contact Alejandra Valencia at [email protected]

Dr. Trung “Tim” Nguyen
Division of Gynecologic Oncology
UCSF Fresno


A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)

For more information about this trial, please contact Alejandra Valencia at [email protected]

Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno


Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of The Primary Tumor in Metastatic Prostate Cancer

For more information about this trial, please contact Alejandra Valencia at [email protected]  

Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno


PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib with Nivolumab; a Phase III in Metastatic Untreated Renal Cell Cancer (PDIGREE)

For more information about this trial, please contact Kelly Meehan at [email protected]

Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno


Prevalence of non-alcoholic fatty liver disease in school-age children in Central Valley and the effect of nutritional intervention on the disease trajectory

For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].

Dr. Marina Roytman
Department of Medicine
UCSF Fresno

 


Introducing Palliative Care (PC) within the treatment of End Stage Liver Disease (ESLD): A Cluster Randomized Controlled Trial (PAL-LIVER)

For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].

Dr. Marina Roytman
Department of Medicine
UCSF Fresno


A Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver-related Outcomes in Patients with Well-compensated (Child-Pugh A) Non-alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH OUTCOMES)

For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].

Dr. Marina Roytman
Department of Medicine
UCSF Fresno


A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy and Safety of Rifaximin Soluble Sold Dispersion (SSD) Tablets For The Delay Of Encephalopathy Decompensation In Cirrhosis (RED-C)

For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].

Dr. Marina Roytman
Department of Medicine
UCSF Fresno


Expanded Access IND Protocol: Use of Tecovirimat (TPOXX) for treatment of Human Non- Variola Orthopoxvirus Infections in Adults and Children (STOMP)

For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].

Dr. Geetha Sivasubramanian
Infectious Disease
UCSF Fresno


Development of an Institution-Based Registry for Coccidioidomycosis: A Retrospective and Prospective Analysis to Inform Diagnoses, Treatment and Disease Burden in Fresno County (COCCI REGISTRY)

The purpose of this registry is to develop and utilize an institution-based registry to identify and study patients with clinically relevant coccidioidomycosis infections

Dr. Robert Libke                   Dr. Geetha Sivasubramanian                    Dr. Mohamed Fayed
Infectious Disease               Infectious Disease                                       Pulmonary Critical Care
UCSF Fresno                        UCSF Fresno                                                UCSF Fresno


MIRAVISTA NEXT GENERATION COCCIDIOIDES IGG AND IGM ANTIBODY ENZYME IMMUNOASSAY EVALUATION

For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].

Dr. Geetha Sivasubramanian
Infectious Disease
UCSF Fresno


Regulatory T Cell Function in Predicting Valley Fever

For more information about this trial, please contact the corresponding research coordinator Yasmine Hernandez at [email protected]

Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno


Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis (Sands-PPC)

For more information about this trial, please contact the corresponding research coordinator Yasmine Hernandez at [email protected]

Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno


DREAM:  Discovering Cancer Risks from Environmental Contaminants and Maternal/Child Health (DREAM Cohort)

For more information about this trial, please contact the corresponding research coordinator Ashley Gutierrez at [email protected]

Dr. Amy Autry
Department of Obstetrics and Gynecology
UCSF Fresno 


Residual Volume Reversibility in Asthma (ReVoReA) Study

The Residual Volume Reversibility in Asthma (ReVoReA) study compares the Performance of Spirometry and Lung Volume Reversibility Indices and their Association with Serum Inflammatory Markers in Asthmatics and Age-Gender Matched Normal Controls

Dr. Jose Vempilly
Department of Medicine
UCSF Fresno 


A STUDY to evaluate the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab (anti-IL-33 mAb)

For more information about this trial, please contact the corresponding research coordinator Adrian Torres at [email protected]

Dr. Vipal Jain
Division of Pulmonary and Critical Care Medicine
UCSF Fresno


A REGISTRY FOR PATIENTS WHO HAVE RECEIVED EXTRACORPOREAL MEMBRANE OXYGENATION

Retrospective Review of Outcomes of all patients receiving ECMO following the inception of the ECMO Team

Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno 


Study Evaluating The Efficacy And Safety Of Vixarelimab Compared With Placebo In Patients With Idiopathic Pulmonary Fibrosis And In Patients With Systemic Sclerosis Associated Interstitial Lung Disease (MOONSCAPE)

For more information about this trial, please contact the corresponding research coordinator Yasmine Hernandez at [email protected]

Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno 


A Registry for the Lung Nodule Clinic

Lung Nodule Clinic Impact Study’s purpose is to examine the overall impact the Lung Nodule clinic has had in the Central valley in the detection of Lung cancer and connection of care.

Dr. Michael Peterson
Y. Frank and Roxie Moradian Chair in Medicine
UCSF Professor of Medicine
UCSF Fresno Associate Dean for UME and Research


Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared with Placebo for the Treatment of Patients with Mycobacterium avium Complex (MAC) Pulmonary Disease

For more information about this trial, please contact the corresponding research coordinator Maria Hernandez at [email protected]

Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno 


A study to evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC) (ENCORE)

For more information about this trial, please contact the corresponding research coordinator Maria Hernandez at [email protected]

Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno 


ARTISAN (Afterload Reduction To Improve Right Ventricular Structure And FuNction)

For more information about this trial, please contact the corresponding research coordinator Sonia Garcia at [email protected]

Dr. Eyad Almasri
Division of Pulmonary and Critical Care Medicine
UCSF Fresno


Retrospective study for the Evaluation of Pulmonary Arterial Hypertension (PAH) Patients

Retrospective Evaluation of Pulmonary Arterial Hypertension (PAH) Patients: Real-World Experience from the Trio Health Network

Dr. Eyad Almasri
Division of Pulmonary and Critical Care Medicine
UCSF Fresno


Post-Approval Study of the TREO Abdominal Stent- Graft System (P190015) in Patients with Infrarenal Abdominal Aortic and Aorto-iliac Aneurysms

For more information about this trial, please contact the corresponding research coordinator Adrian Torres at [email protected]

Dr. Sammy Siada
Department of Surgery
UCSF Fresno 


Study of the Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System for Treatment of Calcified Peripheral Arterial Disease (PAD) in Below-the-Knee (BTK) Arteries

For more information about this trial, please contact the corresponding research coordinator Adrian Torres at [email protected]

Dr. Leigh Ann O’Banion
Department of Surgery
UCSF Fresno